Published in Br Med J (Clin Res Ed) on December 17, 1983
Epithelial hyperplasia in human polycystic kidney diseases. Its role in pathogenesis and risk of neoplasia. Am J Pathol (1987) 1.04
Acquired cystic disease of the kidney: an indication for renal transplantation? Br Med J (Clin Res Ed) (1986) 0.76
Cyst infection in acquired renal cystic disease. Br Med J (Clin Res Ed) (1987) 0.75
Metastatic hypernephroma from a native kidney after cadaver renal transplantation. Postgrad Med J (1985) 0.75
Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol (1977) 1.83
Acquired renal cysts in uremic patients--in vivo demonstration by computed tomography. Clin Nephrol (1980) 1.22
Acquired cystic disease of kidney in chronic dialysis patients. Urology (1981) 1.07
Spontaneous retroperitoneal hemorrhage in chronically hemodialyzed patients. Nephron (1978) 1.06
Spontaneous retroperitoneal bleeding in patients on chronic hemodialysis. Ann Intern Med (1977) 1.05
The pathogenesis of drug-induced renal cystic disease. Kidney Int (1974) 1.05
Atypical cysts, acquired renal cystic disease, and renal cell tumors in end stage dialysis kidneys. Lab Invest (1980) 0.96
Studies on "end-stage" kidneys. Nodule formation in intrarenal arteries and arterioles. Lab Invest (1977) 0.94
Development of acquired cystic disease and adenocarcinoma of the kidney in glomerulonephritic chronic hemodialysis patients. Clin Nephrol (1980) 0.92
Nephron obstruction in nordihydroguaiaretic acid-induced renal cystic disease. Kidney Int (1979) 0.92
Absence of anemia in maintenance hemodialysis. Int J Artif Organs (1981) 0.91
Association between rising haemoglobin concentration and renal cyst formation in patients on long term regular haemodialysis treatment. Proc Eur Dial Transplant Assoc (1983) 0.90
Acquired cystic transformation of the kidneys of haemodialysed patients. Virchows Arch A Pathol Anat Histol (1980) 0.89
Cystic transformation of end-stage kidneys in patients undergoing hemodialysis. Int J Artif Organs (1980) 0.88
Function and structure in the diphenylamine-exposed kidney. J Clin Invest (1976) 0.86
Acquired renal cysts and tumors superimposed on chronic primary kidney diseases. An autopsy study of 24 patients. Pathol Res Pract (1980) 0.82
Renal arteriovenous fistula treated by catheter embolization. Br J Radiol (1973) 0.82
Renal adenoma -- a misnomer. Urology (1979) 0.81
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science (2001) 23.83
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (1999) 23.45
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell (2001) 19.75
Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res (2000) 5.74
Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem (2000) 5.58
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci U S A (1997) 5.42
The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol (2000) 5.21
Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J (2001) 5.20
Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer. Proc Natl Acad Sci U S A (1994) 4.10
bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med (1993) 4.05
Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet (1986) 4.04
Legionnaires' disease in a transplant unit: isolation of the causative agent from shower baths. Lancet (1980) 4.04
Quantitative histological studies on age changes in bone. J Pathol Bacteriol (1967) 3.69
Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood (1998) 3.67
Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci U S A (1993) 3.29
HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res (2001) 3.27
Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit. J Biol Chem (1997) 3.23
A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax (1969) 3.18
International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int (1993) 3.11
A method for the quantitation of small intestinal biopsy specimens. J Clin Pathol (1972) 2.96
Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem (1995) 2.89
A quantitative study of bronchial mucous gland volume, emphysema and smoking in a necropsy population. J Pathol (1971) 2.83
Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J Biol Chem (1995) 2.80
Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet (2001) 2.75
Functional analysis of an oxygen-regulated transcriptional enhancer lying 3' to the mouse erythropoietin gene. Proc Natl Acad Sci U S A (1991) 2.67
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res (2001) 2.66
The post-mortem incdence of pulmonary embolism in a hospital population. Br J Surg (1968) 2.66
Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet (2001) 2.56
Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet (1998) 2.53
A comparison of three methods of measuring emphysema. Hum Pathol (1970) 2.40
Activation of the HIF pathway in cancer. Curr Opin Genet Dev (2001) 2.38
Quantitative aspects of placental structure. J Pathol Bacteriol (1966) 2.30
The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells. J Biol Chem (1996) 2.30
Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor-1alpha. J Biol Chem (1999) 2.28
Quantitative methods in the study of pulmonary pathology. Thorax (1962) 2.16
Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int (1993) 2.07
Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sci U S A (1996) 2.00
Electrocardiographic measures of left ventricular hypertrophy show greater heritability than echocardiographic left ventricular mass. Eur Heart J (2002) 1.89
Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol (1977) 1.83
Targeting gene expression to hypoxic tumor cells. Nat Med (1997) 1.82
Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure. Lancet (1974) 1.80
Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1 alpha-subunit (HIF-1alpha). Characterization of hif-1alpha-dependent and -independent hypoxia-inducible gene expression. J Biol Chem (1998) 1.78
Clinical observations on the effects of debrisoquine sulphate in patients with high blood-pressure. Br Med J (1966) 1.67
Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene (2000) 1.57
Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. Blood (2001) 1.54
Cancer in patients receiving dialysis. Br Med J (1980) 1.52
Target gene selectivity of hypoxia-inducible factor-alpha in renal cancer cells is conveyed by post-DNA-binding mechanisms. Br J Cancer (2007) 1.50
New approach to assessing lung tumours in man. J Clin Pathol (1986) 1.50
Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol (1995) 1.50
Rapid genetic analysis of families with polycystic kidney disease 1 by means of a microsatellite marker. Lancet (1991) 1.44
Age-dependent expression of the erythropoietin gene in rat liver and kidneys. J Clin Invest (1992) 1.43
Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component. Lancet (1991) 1.42
Immunoperoxidase staining of formalin-fixed, paraffin-embedded, human renal biopsies with a comparison of the peroxidase-antiperoxidase (PAP) and indirect methods. J Clin Pathol (1981) 1.41
Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies. J Clin Pathol (1987) 1.41
Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR. Role of hypoxia-inducible factor-1. Eur J Biochem (1996) 1.41
Human lung tumours may coexpress different classes of intermediate filaments. J Clin Pathol (1986) 1.40
Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene. Br J Cancer (2004) 1.39
Late renal failure due to prostatic outflow obstruction: a preventable disease. BMJ (1989) 1.38
Morphometry of the human placenta. Br Med Bull (1966) 1.35
The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Oncogene (2001) 1.34
Some observations on the quantitative anatomy of the kidney. J Pathol (1973) 1.30
The pVHL-hIF-1 system. A key mediator of oxygen homeostasis. Adv Exp Med Biol (2001) 1.29
Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload. Q J Med (1979) 1.28
Late referral for maintenance dialysis. Br Med J (Clin Res Ed) (1984) 1.25
Effect of inhibitors of oxidative phosphorylation on erythropoietin mRNA in isolated perfused rat kidneys. Am J Physiol (1991) 1.25
Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol (1992) 1.23
Human lung tumours: a correlation of antigenic profile with histological type. Histopathology (1985) 1.22
Ki-67 immunostaining and survival in operable lung cancer. Histopathology (1991) 1.22
Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysis. J Clin Pathol (1987) 1.21
The regulation of interleukin-8 by hypoxia in human macrophages--a potential role in the pathogenesis of the acute respiratory distress syndrome (ARDS). Mol Med (2001) 1.21
Endothelin: an important factor in acute renal failure? Lancet (1988) 1.19
Targeting tumors through the HIF system. Nat Med (2000) 1.19
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer. Br J Cancer (2002) 1.16
Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin. Biochem J (1996) 1.15
Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J Clin Invest (1992) 1.15
The interstitial response to renal injury: fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. Kidney Int (1997) 1.15
Iron metabolism in transgenic mice with hypoplastic anaemia due to incomplete deficiency of erythropoietin. Br J Haematol (1997) 1.14
Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation. Lancet (1987) 1.13
Distribution of fibronectin in normal and diseased human kidneys. J Clin Pathol (1980) 1.12
Late onset post-traumatic hypothalamic hypothermia. J Neurol Neurosurg Psychiatry (1983) 1.08
Toxemia of pregnancy in sheep: a clinical, physiological, and pathological study. J Clin Invest (1969) 1.07
Organ distribution of erythropoietin messenger RNA in normal and uremic rats. Kidney Int (1991) 1.07
Regulation of the Drosophila bHLH-PAS protein Sima by hypoxia: functional evidence for homology with mammalian HIF-1 alpha. Biochem Biophys Res Commun (1998) 1.07
Signalling cross talk of the HIF system: involvement of the FIH protein. Curr Pharm Des (2009) 1.07
The pathology of asthma. Ciba Found Study Group (1971) 1.06
Cellular heterogeneity in lung cancer. Histopathology (1986) 1.04
Simple method for early detection of peritonitis in patients on continuous ambulatory peritoneal dialysis. Lancet (1980) 1.04
The pathology of pulmonary embolism. Br J Surg (1968) 1.01
Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing. IUBMB Life (2001) 1.00
A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months. Transplantation (1983) 1.00
Diphenylene iodonium inhibits the induction of erythropoietin and other mammalian genes by hypoxia. Implications for the mechanism of oxygen sensing. Eur J Biochem (1995) 1.00
Cyclosporin and renal graft histology. J Clin Pathol (1986) 0.99
Acute interstitial nephritis and erythroderma associated with diflunisal. Br Med J (1980) 0.99
Clinical and biopsy findings in temporal arteritis. Ann Rheum Dis (1968) 0.98
Characterisation of functional domains within the mouse erythropoietin 3' enhancer conveying oxygen-regulated responses in different cell lines. Biochim Biophys Acta (1994) 0.98
Interleukin 4 receptor expression on human lung tumors and normal lung. Cancer Res (1991) 0.97